Treatment failure Day 63 · adults and children with uncomplicated P falciparum malaria
Dihydroartemisinin‐piperaquine leads to lower treatment failure Day 63 compared with artemether‐lumefantrine (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · patients with managing pulmonary tuberculosis
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
Sputum Conversion by 2 months · patients with managing pulmonary tuberculosis
The intervention may leads to higher sputum Conversion by 2 months (low certainty).
1 finding from 1 review
Intervention not reported
Sputum conversion at 6 months · patients with managing pulmonary tuberculosis
The intervention showed no clear difference in sputum conversion at 6 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Clinical Improvement at 1 month · patients with managing pulmonary tuberculosis
It is very uncertain whether the intervention changes clinical Improvement at 1 month (very low certainty).
1 finding from 1 review
Intervention not reported
Parasitological failure at 1 month · People with S. mansoni infection
The intervention probably leads to higher parasitological failure at 1 month (moderate certainty).
1 finding from 1 review
Intervention not reported
Parasitological failure at 1 month · People with S. mansoni infection
The intervention probably leads to higher parasitological failure at 1 month (moderate certainty).
1 finding from 1 review
Parasitological failure at 1 month · People with S. mansoni infection
It is very uncertain whether oxamniquine 40 mg/kg changes parasitological failure at 1 month compared with praziquantel 40 mg/kg (very low certainty).
1 finding from 1 review
Parasitological failure at 1 month · People with S. mansoni infection
It is very uncertain whether artesunate (12 mg/kg) plus praziquantel (40 mg/kg) changes parasitological failure at 1 month compared with praziquantel (40 mg/kg) alone (very low certainty).
1 finding from 1 review
P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1
Primaquine five days probably leads to higher P. vivax parasitaemia detected > 30 days after starting primaquine compared with 14 days (moderate certainty).
1 finding from 1 review
P. vivax parasitaemia detected > 30 days after starting primaquine · Children and adults with blood smear positive P. vivax malaria1
It is very uncertain whether primaquine (weekly for eight weeks) changes P. vivax parasitaemia detected > 30 days after starting primaquine compared with daily primaquine (very low certainty).
1 finding from 1 review
Serious adverse events · Children and adults with blood smear positive P. vivax malaria1
1 finding from 1 review
Adverse events · Children and adults with blood smear positive P. vivax malaria1
1 finding from 1 review
Intervention not reported
P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1
The intervention showed no clear difference in P. vivax parasitaemia detected > 30 days after starting primaquine (high certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Intervention not reported
Other adverse events · People with P. vivax malaria1
1 finding from 1 review
Intervention not reported
P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1
The intervention leads to lower P. vivax parasitaemia detected > 30 days after starting primaquine (high certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Intervention not reported
Other adverse events · People with P. vivax malaria1
1 finding from 1 review
Serious adverse events · People with P. vivax malaria1
1 finding from 1 review